Altimmune, Inc. (ALT): Price and Financial Metrics
ALT Price/Volume Stats
Current price | $8.05 | 52-week high | $14.84 |
Prev. close | $7.47 | 52-week low | $2.48 |
Day low | $7.52 | Volume | 4,753,700 |
Day high | $8.42 | Avg. volume | 3,874,009 |
50-day MA | $7.06 | Dividend yield | N/A |
200-day MA | $7.59 | Market Cap | 572.56M |
ALT Stock Price Chart Interactive Chart >
Altimmune, Inc. (ALT) Company Bio
Altimmune, Inc., a clinical stage biopharmaceutical company, focused developing treatments for liver disease, immune modulating therapies, and vaccines. The company develops HepTcell, an immunotherapeutic product candidate that has completed Phase I clinical trial for patients chronically infected with the hepatitis B virus; NasoShield, an anthrax vaccine to provide for protection after a single intranasal administration; NasoVAX, a recombinant intranasal vaccine product candidate; and AdCOVID, a single-dose intranasal vaccine to protect against COVID-19 Its preclinical stage products include ALT-801, a novel peptide-based dual GLP-1/Glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis; and ALT-702, an investigational tumor immunostimulant for treating cancer. The company also develops veterinary product candidates. It has a collaboration with the University of Alabama at Birmingham for the development of AdCOVID. Altimmune, Inc. is headquartered in Gaithersburg, Maryland.
ALT Price Returns
1-mo | 18.38% |
3-mo | 15.99% |
6-mo | 9.82% |
1-year | 214.45% |
3-year | -21.08% |
5-year | 396.91% |
YTD | -28.44% |
2023 | -31.61% |
2022 | 79.59% |
2021 | -18.79% |
2020 | 496.83% |
2019 | -8.25% |
Continue Researching ALT
Here are a few links from around the web to help you further your research on Altimmune Inc's stock as an investment opportunity:Altimmune Inc (ALT) Stock Price | Nasdaq
Altimmune Inc (ALT) Stock Quote, History and News - Yahoo Finance
Altimmune Inc (ALT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...